Abstract:The most significant dysregulation occurred in excitatory neurons and oligodendrocyte precursor cells in the epileptogenic cortex of FCD IIIa patients. The DAB1high excitatory neurons subpopulation mediates neuronal immunity characteristically in FCD IIIa. Western blotting and immunofluorescence validated the changes in protein expression levels caused by some of the key genes. Background Focal cortical dysplasia (FCD) is a heterogeneous group of cortical developmental malformations that constitute a common cause of medically intractable epilepsy. FCD type IIIa (FCD IIIa) refers to temporal neocortex alterations in architectural organisation or cytoarchitectural composition in the immediate vicinity of hippocampal sclerosis. Slight alterations in the temporal neocortex of FCD IIIa patients pose a challenge for the preoperative diagnosis and definition of the resection range. Methods We have performed multimodal integration of single‐nucleus RNA sequencing and single‐nucleus assay for transposase‐accessible chromatin sequencing in the epileptogenic cortex of four patients with FCD IIIa, and three relatively normal temporal neocortex were chosen as controls. Results Our study revealed that the most significant dysregulation occurred in excitatory neurons (ENs) and oligodendrocyte precursor cells (OPCs) in the epileptogenic cortex of FCD IIIa patients. In ENs, we constructed a transcription factor (TF)‐hub gene regulatory network and found DAB1high ENs subpopulation mediates neuronal immunity characteristically in FCD IIIa. Western blotting and immunofluorescence were used to validate the changes in protein expression levels caused by some of the key genes. The OPCs were activated and exhibited aberrant phenotypes in FCD IIIa, and TFs regulating reconstructed pseudotime trajectory were identified. Finally, our results revealed aberrant intercellular communication between ENs and OPCs in FCD IIIa patients. Conclusions Our study revealed significant and intricate alterations in the transcriptomes and epigenomes in ENs and OPCs of FCD IIIa patients, shedding light on their cell type‐specific regulation and potential pathogenic involvement in this disorder. This work will help evaluate the pathogenesis of cortical dysplasia and epilepsy and explore potential therapeutic targets. Key points Paired snRNA‐seq and snATAC‐seq data were intergrated and analysed to identify crucial subpopulations of ENs and OPCs in the epileptogenic cortex of FCD IIIa patients and explore their possible pathogenic role in the disease. A TF‐hub gene regulatory network was constructed in ENs, and the DAB1high Ex‐1 mediated neuronal immunity was characterstically in FCD IIIa patients. The OPCs were activated and exhibited aberrant phenotypes in FCD IIIa patients, and TFs regulating reconstructed pseudotime traectory were identified. Aberrant intercelluar communications between ENs and OPCs in FCD IIIa patients were identified.

Spatial transcriptomics in focal cortical dysplasia type IIb

Somatic Variants in New Candidate Genes Identified in Focal Cortical Dysplasia Type II

Transcriptomic profiling of high- and low-spiking regions reveals novel epileptogenic mechanisms in focal cortical dysplasia type II patients

Spatial omics reveals molecular changes in focal cortical dysplasia type II

Multimodal mapping of regional brain vulnerability to focal cortical dysplasia

Excitatory neurons and oligodendrocyte precursor cells are vulnerable to focal cortical dysplasia type IIIa as suggested by single‐nucleus multiomics

Automated Detection of Focal Cortical Dysplasia Based on Magnetic Resonance Imaging and Positron Emission Tomography.

Pathogenesis and Therapeutic Targets of Focal Cortical Dysplasia Based on Bioinformatics Analysis

Pathological Networks Involving Dysmorphic Neurons in Type II Focal Cortical Dysplasia

Identification and verification of key molecules in the epileptogenic process of focal cortical dysplasia

Multimodal single-cell profiling reveals neuronal vulnerability and pathological cell states in focal cortical dysplasia

The clinico-pathological characterisation of focal cortical dysplasia type IIb genetically defined by MTOR mosaicism

The clinico-pathological characterisation of focal cortical dysplasia type IIb genetically defined by <i>MTOR</i> mosaicism

Automated Detection of Focal Cortical Dysplasia Type II with Surface-Based Magnetic Resonance Imaging Postprocessing and Machine Learning

Identification of pericyte loss and neutrophils infiltration in Focal cortical dysplasia by Integrated Analysis of Single-Cell and Bulk RNA-Sequencing

Focal cortical dysplasia type II-dependent maladaptive myelination in the human frontal lobe

Expression profiles of α-synuclein in cortical lesions of patients with FCD IIb and TSC, and FCD rats

Identification of Genetic Characteristics in Pediatric Epilepsy with Focal Cortical Dysplasia Type 2 Using Deep Whole-Exome Sequencing

GABAergic Interneuron and Neurotransmission Are Mtor-Dependently Disturbed in Experimental Focal Cortical Dysplasia

Neuroimaging gradient alterations and epileptogenic prediction in focal cortical dysplasia IIIa

Upregulation of HMGB1-TLR4 inflammatory pathway in focal cortical dysplasia type II